In the present study, we found that CD14 dimCD16high non-classical Mo had a positive correlation with serum IL-17A from 12–16 days after stroke, suggesting that CD16+ monocytes producing IL-17 have a role in the pathogenesis of brain ischemia after the acute phase. Here, IL17A is linked to stroke disorder.